Last 55,100 KRW
Change Today +2,200 / 4.16%
Volume 99.5K
As of 1:13 AM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

cell biotech co ltd (049960) Snapshot

Open
53,000
Previous Close
52,900
Day High
55,600
Day Low
53,000
52 Week High
10/28/14 - 62,500
52 Week Low
01/2/14 - 18,550
Market Cap
517.9B
Average Volume 10 Days
64.4K
EPS TTM
1,010
Shares Outstanding
9.4M
EX-Date
12/27/13
P/E TM
54.6x
Dividend
150.00
Dividend Yield
0.27%
Current Stock Chart for CELL BIOTECH CO LTD (049960)

Related News

No related news articles were found.

cell biotech co ltd (049960) Related Businessweek News

No Related Businessweek News Found

cell biotech co ltd (049960) Details

Cell Biotech Co., Ltd., a biotechnology company, develops and sells lactic acid bacteria products based on fermentation and coating technology in South Korea. The company also offers probiotics. Its products are used in various fields, including medicines, dairy products, veterinary medicines, functional foods, raw materials for cosmetics, and oriental herbal medicines. The company also exports its products to 35 countries, including the United States, Europe, Japan, and Asia. Cell Biotech Co., Ltd. was founded in 1995 and is headquartered in Gimpo, South Korea.

Founded in 1995

cell biotech co ltd (049960) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

cell biotech co ltd (049960) Key Developments

Cell Biotech Co. Ltd. Presents at Korea Corporate Day - Hong Kong, Oct-14-2014

Cell Biotech Co. Ltd. Presents at Korea Corporate Day - Hong Kong, Oct-14-2014 . Venue: Nomura Hong Kong Headquarters, 30/F Two International Finance, Centre, 8 Finance Street Central, Hong Kong, Hong Kong.

Cell Biotech Co. Ltd., Annual General Meeting, Mar 21, 2014

Cell Biotech Co. Ltd., Annual General Meeting, Mar 21, 2014., at 10:00 Korea Standard Time. Location: Gimpo, Gyeonggi-do, 50 wolgotmyeon beongil aegibong. Agenda: To consider statement of financial position, income statement and appropriation of retained earnings; to consider election of directors; to consider approval of director remuneration; to consider approval of the remuneration; and to consider other references concerning investment decisions.

Cell Biotech Co. Ltd., Annual General Meeting, Mar 15, 2013

Cell Biotech Co. Ltd., Annual General Meeting, Mar 15, 2013., at 10:00 Korea Standard Time. Location: head office 3rd Floor. Agenda: To approve the financial position, income statement, and statement of appropriation of retained earnings; to appoint the directors; to consider the approval of directors' remuneration limit; to consider the audit remuneration limit; and to consider the Other references concerning investment decisions.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
049960:KS 55,100.00 KRW +2,200

049960 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 049960.
View Industry Companies
 

Industry Analysis

049960

Industry Average

Valuation 049960 Industry Range
Price/Earnings 41.1x
Price/Sales 10.4x
Price/Book 8.3x
Price/Cash Flow 48.3x
TEV/Sales 12.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CELL BIOTECH CO LTD, please visit www.cellbiotech.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.